| 注册
首页|期刊导航|中国全科医学|胸腔化疗联合热疗治疗癌性胸腔积液有效性和安全性的Meta分析

胸腔化疗联合热疗治疗癌性胸腔积液有效性和安全性的Meta分析

胡月 李征 曲雁 丁俊琴 祖淑文 李海滨 杨志慧 李燕红 谢俊芳

中国全科医学2017,Vol.20Issue(32):4034-4041,8.
中国全科医学2017,Vol.20Issue(32):4034-4041,8.DOI:10.3969/j.issn.1007-9572.2017.00.047

胸腔化疗联合热疗治疗癌性胸腔积液有效性和安全性的Meta分析

Efficacy and Safety of Intrathoracic Chemotherapy Combined with Thermotherapy for Malignant Pleural Effusion: a Meta-analysis

胡月 1李征 2曲雁 3丁俊琴 4祖淑文 5李海滨 1杨志慧 1李燕红 1谢俊芳1

作者信息

  • 1. 050051 河北省石家庄市,河北医科大学第三医院西院全科医学科
  • 2. 730000 甘肃省兰州市,兰州大学第一附属医院普外科
  • 3. 050051 河北省石家庄市,河北医科大学第三医院科研处
  • 4. 050051 河北省石家庄市,河北医科大学第三医院护理部
  • 5. 050051 河北省石家庄市,河北医科大学第三医院教务处
  • 折叠

摘要

Abstract

Objective To systematically review the efficacy and safety of intrathoracic chemotherapy combined with thermotherapy (ITCT) for malignant pleural effusion (MPE).Methods From August 2015 to January 2016,a computerbased retrieval was performed in foreign databases such as Cochrane Library,PubMed,EMBase,Web of Science and Chinese ones such as CBM,CNKI,VIP and Wanfang,and supplementary retrieval was also performed with other sources.All relevant randomized controlled trials (RCTs) were collected to compare ITCT (ITCT group) and monotherapy of intrathoracic chemotherapy (ITC group).We extracted the relevant information from the literatures,including the first author,published time,sample size,age,Karnofsky performance status,chemotherapy regimens and outcome indicators.Then we assessed the methodologic quality of included studies.Results A total of 23 literatures were included,comprising 1 647 patients,including 819 in the ITCT group and 828 in the ITC group.Five studies reported random methods,yet none of the included studies mentioned the concealment of allocation and blinding.The baseline comparability of the two groups had fine balance.One study had loss of follow-up.There was no selective outcome reporting in any of the included studies.Total effective rate [OR =3.72,95% CI (2.92,4.74)],complete remission rate [OR =2.24,95% CI (1.81,2.78)] and improving rate of life quality [OR =3.66,95% CI (2.64,5.07)] of ITCT group were superior to those of ITC group and there were all significant difference (P < 0.05).There were no significant difference between the two groups on the incidence of nausea and vomiting [OR =0.80,95%CI (0.60,1.06)],leukocytopenia [OR=0.81,95%CI (0.60,1.10)],fever [OR =0.98,95%CI (0.69,1.40)],hepatic lesion [OR =0.45,95% CI (0.11,1.81)],pneumothorax [OR =0.41,95% CI (0.06,2.91)] and skin scald [OR =5.33,95% CI (0.91,31.14)].The incidence of stethalgia in ITCT group was lower than ITC group [OR =0.34,95%CI (0.16,0.74)],the incidence of subcutaneous fat scleroma in ITCT group was higher than ITC group [OR =6.27,95%CI (1.08,36.27)],and there were all significant difference (P<0.05).Conclusion Compared with ITC,ITCT can significant improve short-term curative effect and life quality of patients with MPE;additionally,it is safe and feasible.But its long-term survival rate and security still needs to be further verified by more large sample and high quality studies.

关键词

胸腔积液,恶性/化学疗法,肿瘤/热疗/疗效/Meta分析

Key words

Pleural effusion, malignant/Chemotherapy, cancer/Thermotherapy/Effectiveness/Meta-analysis

分类

医药卫生

引用本文复制引用

胡月,李征,曲雁,丁俊琴,祖淑文,李海滨,杨志慧,李燕红,谢俊芳..胸腔化疗联合热疗治疗癌性胸腔积液有效性和安全性的Meta分析[J].中国全科医学,2017,20(32):4034-4041,8.

中国全科医学

OA北大核心CSTPCD

1007-9572

访问量0
|
下载量0
段落导航相关论文